The Patent Finder

Integrated Biotherapeutics LLC

Also on record
Records under this name other than patents Integrated Biotherapeutics LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Integrated Biotherapeutics LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,109,036Immunogenic Composition Comprising Alpha-Hemolysin Oligopeptides
now held by Abvacc, Inc.
In force
 · High confidence
In forceHigh confidence
US 10,023,848Immunogenic Composition Comprising Panton-Valentine Leukocidin (PVL) Derived Polypeptides
now held by Abvacc, Inc.
In force
 · High confidence
In forceHigh confidence
US 9,815,872Toxoid Peptides Derived from Phenol Soluble Modulin, Delta Toxin, Superantigens, and Fusions Thereof
now held by Abvacc, Inc.
In force
 · High confidence
In forceHigh confidence
US 10,174,085Toxoid Peptides Derived From Phenol Soluble Modulin, Delta Toxin, Superantigens, and Fusions Thereof
now held by Abvacc, Inc.
In force
 · High confidence
In forceHigh confidence
US 11,028,153Targeting Immunological Functions to the Site of Bacterial Infections Using Cell Wall Targeting Domains of Bacteriolysins
now held by Abvacc, Inc.
In force
 · High confidence
In forceHigh confidence
US 10,487,140Targeting Immunological Functions to the Site of Bacterial Infections Using Cell Wall Targeting Domains of Bacteriolysins
now held by Abvacc, Inc.
In force
 · High confidence
In forceHigh confidence
US 10,611,827Non-Human Primate-Derived Pan-Ebola and Pan-Filovirus Monoclonal Antibodies Directed Against Envelope Glycoproteins
In force
 · High confidence
In forceHigh confidence
US 11,186,626Broadly Neutralizing Antibody Targeting the Ebolavirus Glycoprotein Internal Fusion Loop
In force
 · High confidence
In forceHigh confidence
US 11,421,021Immunogenic Compositions Comprising Staphylococcus Aureus Leukocidin Luka and Lukb Derived Polypeptides
now held by Abvacc, Inc.
In force
 · High confidence
In forceHigh confidence
US 11,260,120Immunogenic Composition Comprising a Fusion Peptide Derived from Superantigen Toxoids
now held by Abvacc, Inc.
In force
 · High confidence
In forceHigh confidence
10 of 20 records shown.
Pro members see all 20.
Pro members: see all 20 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited